Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
684
-
Total 13F shares, excl. options
-
196M
-
Shares change
-
-946K
-
Total reported value, excl. options
-
$4.08B
-
Value change
-
-$41.9M
-
Put/Call ratio
-
0.6
-
Number of buys
-
265
-
Number of sells
-
-365
-
Price
-
$20.81
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q2 2023
809 filings reported holding OGN - Organon & Co. - Common Stock as of Q2 2023.
Organon & Co. - Common Stock (OGN) has 684 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 196M shares
of 260M outstanding shares and own 75.39% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (31.7M shares), BlackRock Inc. (16.2M shares), Mawer Investment Management Ltd. (13.2M shares), STATE STREET CORP (13M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (8.84M shares), Invesco Ltd. (8.28M shares), JANUS HENDERSON GROUP PLC (5.95M shares), GEODE CAPITAL MANAGEMENT, LLC (5.59M shares), LORD, ABBETT & CO. LLC (5.23M shares), and AMUNDI (4.82M shares).
This table shows the top 684 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.